Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing the Feasibility and Usability of Implementing Professional Use and Self-administered COVID-19 Antigen RDTs in Uganda

NCT05630300 is registered in ClinicalTrials.gov with PATH as lead sponsor.

NCT NCT05630300
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05630300 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing the Feasibility and Usability of Implementing Professional Use and Self-administered COVID-19 Antigen RDTs in Uganda
Lead sponsor
PATH
Phase
Not applicable
Overall status
Completed
Start date
March 1, 2023
Completion date
September 30, 2023
Enrollment
1,280 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 pandemic